30/70 Mixture Recombinant Human Insulin(Tonghua Dongbao Pharmaceutical)

30/70混合重组人胰岛素（通化东宝）

Report date: 2022/01/14 13:23:58

Base Information

Drug Name30/70 Mixture Recombinant Human Insulin(Tonghua Dongbao Pharmaceutical)
Drug Alias Name30/70混合重组人胰岛素注射液（通化东宝）甘舒霖30R
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryMainland China
Original Approved Date2002/05/18
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTonghua Dongbao Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTonghua Dongbao Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A